Home > Products > Active Pharmaceutical Ingredient (API) > Citrate Tofacitinib > (3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate
(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate

(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate

(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylatum est medicamento arthritis rheumatoidei, medicamento arthritis psoriatic, spondylitis medicamento ankylosing, polyarticularis utique arthritis juvenilis idiopathica medicamento, medicamento ulcerativa colitis.

Mitte Inquisitionem

depictio producti

Formulae


(3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylatum est medicamento arthritis rheumatoidei, medicamento arthritis psoriatic, spondylitis medicamento ankylosing, polyarticularis utique arthritis juvenilis idiopathica medicamento, medicamento ulcerativa colitis.

Seres aliases: Tofacitinib Citrate API

Hot Tags: (3R,4R) -4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino) propanetricarboxylate, China, Manufacturer, Supplier, Factory, Quality
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.

Praeclaram praebet, comprehensive mos muneris omnem gradum viae. Priusquam iubes, percontationes reales fac tempus...

X
Crusulis utimur ut meliorem experientiam pasco tibi praebeamus, situm negotiationis et personalize contentus analyse. Hoc situ utendo, ad nostrum crustulorum usum consentis. Privacy Policy